SPN-538
538P401
Approved small_molecule terminated
Quick answer
SPN-538 for Migraine Disorders is a Approved program (small_molecule) at SUPERNUS PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SUPERNUS PHARMACEUTICALS, INC.
- Indication
- Migraine Disorders
- Phase
- Approved
- Modality
- small_molecule
- Status
- terminated